Elke Seewaldt-Becker

1.3k citations
7 papers · 1.1k indexed · 1 hit paper · h-index 7
Topics
Diabetes Treatment and Management (4 papers)Diabetes Management and Research (2 papers)Metabolism, Diabetes, and Cancer (2 papers)

In The Last Decade

Elke Seewaldt-Becker

7 papers receiving 1.0k citations

Hit Papers

Empagliflozin as Add-On to Metformin in Patients With Typ...20142026201820222014100200300

Peers

Elke Seewaldt-Becker
Comparison fields: 5 of 62
  • Endocrinology, Diabetes and Metabolism 972
  • Surgery 588
  • Molecular Biology 510
  • Pharmacology 160
  • Nephrology 84
Replace Katja Rohwedder with:
Katja Rohwedder Germany
Ludwig Merker Germany
S. Durán‐García Spain
Xiaoni Liu China
Michaël J.B. van Baar Netherlands
Silvina Gallo United States
Claire C. J. Dekkers Netherlands
Aurora Merovci United States
Yuka Hayashizaki Japan
Nobuko Maruyama Japan
Elke Seewaldt-Becker relative to Katja Rohwedder Germany Katja Rohwedder's profile →
Citations per field
00.5×1.5×
Katja Rohwedder · 1×
Citations per year

Countries citing papers authored by Elke Seewaldt-Becker

Since Specialization
Citations

This map shows the geographic impact of Elke Seewaldt-Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Seewaldt-Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Seewaldt-Becker more than expected).

Fields of papers citing papers by Elke Seewaldt-Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Seewaldt-Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Seewaldt-Becker. The network helps show where Elke Seewaldt-Becker may publish in the future.

Co-authorship network of co-authors of Elke Seewaldt-Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Seewaldt-Becker. A scholar is included among the top collaborators of Elke Seewaldt-Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Seewaldt-Becker. Elke Seewaldt-Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1
Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trialbreakdown →
315
2 160
3 305
4 231
5 21
6 12
7 11

About Elke Seewaldt-Becker

Elke Seewaldt-Becker is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 7 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), Diabetes Management and Research (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (972 citations), Surgery (588 citations) and Nephrology (84 citations). Elke Seewaldt-Becker has collaborated with scholars based in Germany, United States and Greece. Frequent co-authors include Hans J. Woerle, Ludwig Merker, Marc Weimer, Hans‐Ulrich Häring, Uli C. Broedl, Thomas Meinicke, Stefan Hantel, Sabine Pinnetti, Leo Seman and Tim Heise. Their work appears in journals such as Diabetes Care, European Journal of Medicinal Chemistry and Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026